How Ernst & Young Solved Payment Issues for a Top 10 Pharma
(May 15, 2019)
Sponsored by
Webinar Description:
Slow and inaccurate payments cause a huge financial and administrative burden to research sites. Most sponsors want to improve this process and create a positive relationship with sites but many struggle with the best way to make improvements. Hillel Lehmann will review the strategy he and a Top 10 Pharma used to improve the site payment process & transparency increasing site and study team satisfaction and reducing organizational risk.
The webinar will show how to identify issues and roadblocks in the current process, determine a solution that fits best with your organization, align all stakeholders on the decision, develop an implementation plan, and evaluate the ROI of the new system and process.
Learning Objectives:
- How to examine the current state and set goals for the future desired state
- How to identify the right payments model for your organization
- How to build a compelling business case to make a change
- Steps to ensure a successful implementation
Speakers:
Stuart Thiede
Head, Global Head Financial Lifecycle
IQVIA
Stuart Thiede is responsible for leading the highly skilled and experienced professionals who deliver investigator grant payment services to clinical trial sponsors and CROs. Stuart brings nearly 30 years of experience to IQVIA from companies that provide technology solutions to their clients, with ten years of this experience specific to companies providing software and professional service solutions to the pharmaceutical industry. Stuart’s diverse background includes significant executive roles in finance, operations, service delivery, and account management in enterprises ranging from a Fortune 500 technology company to a high-growth software and professional service mid-market company, to two small start-up enterprises.
Hillel Lehmann
Life Science Strategy
EY
Hillel is a member of Ernst & Young’s Advisory Services Strategy practice, supporting global clients with a range of services from process optimization & automation and post-merger integration. Hillel has supported several large pharma clients in the optimization of integrated clinical development and commercial models through analysis of prime organizational structures and behaviors to drive and scale efficiencies, innovation and better decision making. He also led study start-up transformation initiatives at a large biopharma client to design and implement new solutions that reduce site start-up time, allow for data drive site selection, increase patient retention and built a custom CTMS workflow management tool to provide real time analytics and benchmarking. key site activities. Hillel holds a BA from Columbia University.
Cost: No cost!
Schedule conflict? Register and you'll receive a copy of the recording!
(May 15, 2019)
